ArticleJPGN reports2026
Youngest known case of a pancreatic perivascular epithelioid cell tumor.
Article in JPGN reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Youngest known case of a pancreatic perivascular epithelioid cell tumor.JPGN reports · 2026Article
- Pancreatic Perivascular Epithelioid Cell Tumor: A Case Report and Literature Review.Surgical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perivascular epithelioid cell tumors (PEComas) are a rare type of mesenchymal tumor that can arise in any part of the body. As of 2024, 37 cases of pancreatic PEComas had been reported in the literature with patients ranging in age from 17 to 74 years old. This is the youngest reported case of a pancreatic PEComa in an 8-year-old female presenting with abdominal pain and test findings of biliary obstruction. Magnetic resonance cholangiopancreatography identified the location, size, and obstructive effects of the mass. These findings prompted the performance of an endoscopic retrograde cholangiopancreatography and endoscopic ultrasound with fine-needle aspiration to obtain a tissue sample that revealed the diagnosis of PEComa based on the morphological features and immunohistochemistry. Our patient's tumor was benign, successfully resected, and to date, the child has not had tumor recurrence based upon postsurgical serial imaging, which is consistent with most cases of pancreatic PEComas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.